Anti-Chlamydia trachomatis antibody [6709] (STJ400038)
SPECIFICATIONS
ClonalityMonoclonal
HostMouse
ConjugationUnconjugated
IsotypeIgG2a
ImmunogenChlamydial LPS KDO-trisaccharide
General Information
| Short Description | Mouse monoclonal anti-Chlamydia trachomatis for use in FIA in C.trachomatis samples. Datasheet included with dilution recommendations, and related reagents. |
| Applications | FIA |
| Host | Mouse |
| Reactivity | C.trachomatis |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Clonality | Monoclonal |
| Clone ID | 6709 |
| Isotype | IgG2a |
| Conjugation | Unconjugated |
| Concentration | 5.0 mg/ml (+/-10 %) |
| Formulation | 0.9 % NaCI, 0.095 % NaN3 as a preservative |
| Storage Instruction | Store at 2–8 °C, and do not freeze. |
Target Information
| Immunogen | Chlamydial LPS KDO-trisaccharide |
| Specificity | Antibody recognizes Chlamydia trachomatis LPS. Recognizes C. pneumoniae and C. psittaci. Does not recognize S. minnesota, B. quintana, B. henselae or S. negevensis. |
Additional Info
| Background | C. trachomatis is a obligate intracellular pathogen and can cause numerous disease states in both men and women. Both sexes can display urethritis, proctitis, trachoma, and infertility. The bacterium can cause prostatitis and epididymitis in men. In women, cervicitis, pelvic inflammatory disease (PID) , ectopic pregnancy, and acute or chronic pelvic pain are frequent complications. C. trachomatis is also an important neonatal pathogen, where it can lead to infections of the eye (trachoma) and pulmonary complications. |
Information sourced from Uniprot.org